Cell death induced by 2-phenylethynesulfonamide uncovers a pro-survival function of BAX.
Paolo Mattiolo, Ares Barbero-Farran, Josep Amigó, Marta Ripamonti, Judit Ribas, Jacint Boix
Index: Cancer Lett. 354(1) , 115-21, (2014)
Full Text: HTML
Abstract
PES (2-phenylethynesulfonamide) was initially identified as an inhibitor of p53 translocation to mitochondria and named Pifithrin-µ. Further studies showed that PES selectively killed tumour cells and was thus a promising anticancer agent. PES-induced cell death was characterised by a non-apoptotic, autophagosome-rich phenotype. We observed this phenotype via electron microscopy in wild type (wt) and double Bax-/- Bak-/- (DKO) mouse embryonic fibroblasts (MEFs) treated with PES. We excluded the involvement of effector caspases, BAX and BAK, in causing PES-triggered cell death. Therefore, apoptosis was ruled out as the lethal mode of action of PES. Surprisingly, MEFs containing BAX were significantly protected from PES treatments. BAX overexpression in Bax-/- MEFs confirmed this pro-survival effect. Moreover, this protective effect required the ability of BAX to localise to mitochondrial membranes. Conversely, mitochondrial fusion induced by treatment with Mdivi-1 conferred increased resistance to MEFs subjected to PES treatment. The involvement of BAX in the regulation of mitochondrial dynamics has been reported. We propose the promotion of mitochondrial fusion by BAX to be the pro-survival function attributed to BAX. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Related Compounds
Related Articles:
Aptamer-based polyvalent ligands for regulated cell attachment on the hydrogel surface.
2015-04-13
[Biomacromolecules 16(4) , 1382-9, (2015)]
Polymerization of affinity ligands on a surface for enhanced ligand display and cell binding.
2014-12-08
[Biomacromolecules 15(12) , 4561-9, (2014)]
2014-10-01
[Eur. J. Pharm. Biopharm. 88(2) , 406-14, (2014)]
Use of an enzyme-assisted method to improve protein extraction from olive leaves.
2015-02-15
[Food Chem. 169 , 28-33, (2014)]
2015-04-30
[Int. J. Pharm. 484(1-2) , 283-91, (2015)]